Memory B cell like profiles (MBL) and links to CPI response have been studied in urothelial carcinoma patients on anti-PDL-1 (n = 25), melanoma patients on anti-PD-1 (n = 28), and anti-CTLA-4 therapies (n = 42). Here, CD274 is linked to urothelial carcinoma.